Zobrazeno 1 - 10
of 94
pro vyhledávání: '"Vicente Verez-Bencomo"'
Autor:
Felix Cardoso-San Jorge, Bárbara Baró-Vinent, Marislen Hernández-Hernández, Jessy Pedroso-Fernández, Vicente Veréz-Bencomo
Publikováno v:
VacciMonitor, Vol 31, Iss 2, Pp 83-89 (2022)
En el presente trabajo se realiza la estandarización del procedimiento espectrofotométrico de determinación de polisacárido capsular e intermedios de Neisseria meningitidis serogrupo X, mediante la determinación de los grupos fosfodiéster prese
Externí odkaz:
https://doaj.org/article/d86f73f49a814457aa17cc653d6962d6
Autor:
Nivaldo Linares-Pérez, María E. Toledo-Romaní, Darielys Santana-Mederos, Anaí García-Fariñas, Dagmar García-Rivera, Yury Valdés-Balbín, Vicente Vérez-Bencomo
Publikováno v:
International Journal of Infectious Diseases, Vol 60, Iss C, Pp 98-102 (2017)
A new pneumococcal conjugate vaccine is currently undergoing advanced clinical evaluation prior to its planned introduction in Cuba. The implementation of the pneumococcal vaccination strategy has been designed with consideration of the need to maxim
Externí odkaz:
https://doaj.org/article/03fd23619cb74bc9b1a4c744894958b2
Autor:
Majela González-Miro, Laura Rodríguez-Noda, Mildrey Fariñas-Medina, Dagmar García-Rivera, Vicente Vérez-Bencomo, Bernd H.A. Rehm
Publikováno v:
Heliyon, Vol 3, Iss 4, Pp e00291- (2017)
Streptococcus pneumoniae is a human pathogen responsible for the majority of childhood pneumonia and media otitis cases worldwide. The diversity of its capsular polysaccharides (CPS) results in more than 91 serotypes of which at least 23 are virulent
Externí odkaz:
https://doaj.org/article/b1a8a3a7d7e34bdc9f0515cf30e3f9a6
Autor:
Sana Eybpoosh, Alireza Biglari, Rahim Sorouri, Fatemeh Ashrafian, Mona Sadat Larijani, Vicente Verez-Bencomo, Maria Eugenia Toledo-Romani, Carmen Valenzuela Silva, Mostafa Salehi-Vaziri, Sarah Dahmardeh, Delaram Doroud, Mohammad Banifazl, Ehsan Mostafavi, Anahita Bavand, Amitis Ramezani
Publikováno v:
PLoS Pathogens, Vol 19, Iss 11 (2023)
Externí odkaz:
https://doaj.org/article/d6b736a9670c472fb9cd0b2aa605b7a8
Autor:
Behrokh Farahmand, Mona Sadat Larijani, Fatemeh Fotouhi, Alireza Biglari, Rahim Sorouri, Fahimeh Bagheri Amiri, Ali Eslamifar, Tahmineh Jalali, Mostafa Salehi-Vaziri, Mohammad Banifazl, Sarah Dahmardeh, Azita Eshratkhah Mohammadnejad, Anahita Bavand, Mahsa Tavakoli, Vicente Verez-Bencomo, Ehsan Mostafavi, Hassan Noori Daloii, Fatemeh Ashrafian, Masoumeh Saberpour, Amitis Ramezani
Publikováno v:
Heliyon, Vol 9, Iss 10, Pp e20555- (2023)
COVID-19 pandemic has been managed through global vaccination programs. However, the antibody waning in various types of vaccines came to notice. Hereby, PastoCovac Plus as a protein subunit vaccine was investigated in immunized health care workers b
Externí odkaz:
https://doaj.org/article/648d691f633e440b90bb0a37d594a11f
Autor:
María Eugenia Toledo-Romaní, Mayra García-Carmenate, Carmen Valenzuela-Silva, Waldemar Baldoquín-Rodríguez, Marisel Martínez-Pérez, Meiby Rodríguez-González, Beatriz Paredes-Moreno, Ivis Mendoza-Hernández, Raúl González-Mujica Romero, Oscar Samón-Tabio, Pablo Velazco-Villares, Juan Pablo Bacallao-Castillo, Ernesto Licea-Martín, Misladys Rodríguez-Ortega, Nuris Herrera-Marrero, Esperanza Caballero-González, Liudmila Egües-Torres, Reinaldo Duartes-González, Serguey García-Blanco, Suzette Pérez-Cabrera, Santos Huete-Ferreira, Kirenia Idalmis-Cisnero, Omayda Fonte-Galindo, Dania Meliá-Pérez, Ivonne Rojas-Remedios, Delaram Doroud, Mohammad Mehdi Gouya, Alireza Biglari, Sonsire Fernández-Castillo, Yanet Climent-Ruiz, Yury Valdes-Balbín, Dagmar García-Rivera, Patrick Van der Stuyft, Vicente Verez-Bencomo
Publikováno v:
The Lancet Regional Health. Americas, Vol 18, Iss , Pp 100423- (2023)
Summary: Background: SOBERANA-02 is a COVID-19 conjugate vaccine (recombinant RBD conjugated to tetanus toxoid). Phases 1/2 clinical trials demonstrated high immunogenicity, promoting neutralising IgG and specific T-cell response. A third heterologou
Externí odkaz:
https://doaj.org/article/3dba4ee40a234d2ab6a8e682d6435a15
Autor:
Yury Valdes-Balbin, Darielys Santana-Mederos, Françoise Paquet, Sonsire Fernandez, Yanet Climent, Fabrizio Chiodo, Laura Rodríguez, Belinda Sanchez Ramirez, Kalet Leon, Tays Hernandez, Lila Castellanos-Serra, Raine Garrido, Guang-Wu Chen, Dagmar Garcia-Rivera, Daniel G. Rivera, Vicente Verez-Bencomo
Publikováno v:
ACS Central Science, Vol 7, Iss 5, Pp 757-767 (2021)
Externí odkaz:
https://doaj.org/article/f985a93b2bbb451db45714c249cf4eea
Autor:
Arturo Chang-Monteagudo, Rolando Ochoa-Azze, Yanet Climent-Ruiz, Consuelo Macías-Abraham, Laura Rodríguez-Noda, Carmen Valenzuela-Silva, Belinda Sánchez-Ramírez, Rocmira Perez-Nicado, Tays Hernández-García, Ivette Orosa-Vázquez, Marianniz Díaz-Hernández, María de los Ángeles García-García, Yanet Jerez-Barceló, Yenisey Triana-Marrero, Laura Ruiz-Villegas, Luis Dairon Rodríguez-Prieto, Rinaldo Puga-Gómez, Pedro Pablo Guerra-Chaviano, Yaíma Zúñiga-Rosales, Beatriz Marcheco-Teruel, Mireida Rodríguez-Acosta, Enrique Noa-Romero, Juliet Enríquez-Puertas, Delia Porto-González, Olivia Fernández-Medina, Anet Valdés-Zayas, Guang-Wu Chen, Luís Herrera-Martínez, Yury Valdés-Balbín, Dagmar García-Rivera, Vicente Verez-Bencomo
Publikováno v:
The Lancet Regional Health. Americas, Vol 4, Iss , Pp 100079- (2021)
Background: As a first step towards a vaccine protecting COVID-19 convalescents from reinfection, we evaluated FINLAY-FR-1A vaccine in a clinical trial. Methods: Thirty COVID-19 convalescents aged 22-57 years were studied: convalescents of mild COVID
Externí odkaz:
https://doaj.org/article/54ac04bcc70849c995125a973cce9fdb
Autor:
Maria Eugenia-Toledo-Romani, Carmen Valenzuela-Silva, Minerva Montero-Diaz, Luisa Iniguez-Rojas, Meiby Rodriguez-González, Mery Martinez-Cabrera, Rinaldo Puga-Gómez, Angel German-Almeida, Sonsire Fernandez-Castillo, Yanet Climent-Ruiz, Darielys Santana-Mederos, Lissette Lopez-Gonzalez, Ileana Morales-Suarez, Delaram Doroud, Yury Valdés-Balbín, Dagmar García-Rivera, Patrick Van der Stuyft Van der Stuyft, Vicente Verez-Bencomo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a4c6ff767e25a3ad712a17d14f281cae
https://doi.org/10.2139/ssrn.4397049
https://doi.org/10.2139/ssrn.4397049
Autor:
Franciscary Pi-Estopinan, Jorman Rubino-Moreno, Mayte Amoroto-Roig, Maria Teresa Perez-Guevara, Yury Valdés-Balbín, Laura M. Rodríguez-Noda, Marisel Martinez-Perez, Meiby de la Caridad Rodriguez-Gonzalez, Carmen M Valenzuela-Silva, Dagmar García-Rivera, Rolando Ochoa-Azze, Maura Tamayo-Rodriguez, Raul Gonzalez-Mugica, Vicente Verez-Bencomo, Yanet Chappi-Estevez, Yanet Climent-Ruiz, Belinda Sanchez-Ramirez, Beatriz Paredes-Moreno, Anamary Suarez-Batista, Gretchen Bergado-Baez, Tays Hernandez-Garcia, Alina Díaz-Machado, Alis Martín-Trujillo, Sonia Pérez-Rodríguez, Rocmira Perez-Nicado, Guang-Wu Chen, Marta Dubed-Echevarría, Carlos A. González-Delgado
Publikováno v:
Vaccine. 40:2068-2075
BackgroundThe Receptor Binding Domain (RBD) of the SARS-CoV-2 spike protein is the target for many COVID-19 vaccines. Here we report results for phase 1 clinical trial of two COVID-19 vaccine candidates based on recombinant dimeric RBD (d-RBD).Method